IceCure expands its U.S. ProSense footprint as breast cryoablation moves beyond clinical trials
Discover whether IceCure’s 70% ProSense installation growth can turn breast cryoablation into a scalable alternative to surgery.
Medical Devices & Diagnostics
Medical Devices & Diagnostics
Adagio Medical reports pivotal FULCRUM-VT results as FDA pathway sharpens for vCLAS ablation system
VT ablation remains difficult. Adagio Medical’s pivotal vCLAS data now shifts the question from feasibility to FDA and clinical adoption.